[en] Ionic hydration and electrostriction are very important phenomena in various fields such as medical science, biochemistry, and chemical engineering. The present study is the first to focus on these parameters at infinite dilution. Limiting partial molar volumes (V₂₃^∞) in a solvent (1) − [solute (2) + solute (3)] system were measured at several solute compositions x₃ [= n₃/(n₂ + n₃)] at 30.00 ± 0.05 °C. When the mixed solutes (2 and 3) only slightly ionized, V₂₃^∞ were observed on the additivity line. This result was attributed to the fact that only solvent (1) molecules can exist around an isolated solute (2) molecule or an isolated solute (3) molecule at infinite dilution. However, V₂₃^∞ in water − [pyridine + fatty acid (acetic acid, propionic acid, or butyric acid)] systems negatively deviate from the additivity line. By measuring electrical conductivity (κ) and mixing enthalpy (ΔH_mix), the negative deviations of V₂₃^∞ from the additivity line were attributed to the ionic hydration of pyridine and the fatty acid. As a result, by measuring V₂₃^∞ at several solute compositions, the electrostriction in water − [pyridine + fatty acid] systems was observed. Conversely, V₃^∞ in all 14 [solvent (1) + solvent (2)] − solute (3) systems deviated in complicated ways from the additivity line. Unfortunately, we could not clarify the reason behind this deviation because numerous factors had to be considered. Thus, it was confirmed that the behavior of $V_3^{\mathrm{\infty <!--\; ???\; -->}}$ is much more complicated than that of V₂₃^∞. The solvents used to study V₂₃^∞ and $V_3^{\mathrm{\infty <!--\; ???\; -->}}$ are as follows: water, pyridine, acetic acid, propionic acid, butyric acid, benzene, acetone, chloroform, methanol, ethanol, DMF, carbon tetrachloride, isobutylamine, isobutyl alcohol, n-heptane, and n-octane.

[en] A subset of lung adenocarcinomas harboring an EML4-ALK fusion gene resulting in dominant oncogenic activity has emerged as a target for specific therapy. EML4-ALK fusion confers a characteristic histology and is detected more frequently in never or light smokers and younger patients. To gain insights into etiology and carcinogenic mechanisms we conducted analyses to compare allelotypes of 35 ALK fusion-positive and 95 -negative tumours using single nucleotide polymorphism (SNP) arrays and especially designed software which enabled precise global genomic profiling. Overall aberration numbers (gains + losses) of chromosomal alterations were 8.42 and 9.56 in tumours with and without ALK fusion, respectively, the difference not being statistically significant, although patterns of gain and loss were distinct. Interestingly, among selected genomic regions, oncogene-related examples such as 1p34.3(MYCL1), 7q11.2(EGFR), 7p21.1, 8q24.21(MYC), 16p13.3, 17q12(ERBB2) and 17q25.1 showed significantly less gain. Also, changes in tumour suppressor gene-related regions, such as 9p21.3 (CDKN2A) 9p23-24.1 (PTPRD), 13q14.2 (RB1), were significantly fewer in tumours with ALK fusion. Global genomic comparison with SNP arrays showed tumours with ALK fusion to have fewer alterations in oncogenes and suppressor genes despite a similar overall aberration frequency, suggesting very strong oncogenic potency of ALK activation by gene fusion